You can buy or sell Amgen and other stocks, options, ETFs, and crypto commission-free!
Amgen Inc. Common Stock, also called Amgen, is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Read More Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Thousand Oaks, California
52 Week High
52 Week Low
Top Research Reports for Apple, Amgen & United Technologies
Tuesday, March 26, 2019 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Amgen (AMGN) and United Technologies (UTX). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. You can see all of today’s research reports here >>> Apple’s shares have gained +9.2% in the past year and have outperformed the broader market with the S...
Were Hedge Funds Right About Amgen, Inc. (AMGN)?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips on the charts, usually don't make them change their opinion towards a company.
Verantos Announces Collaboration with Amgen on Real World Evidence
PALO ALTO, Calif., March 26, 2019 /PRNewswire/ -- Verantos, the market leader in regulatory-grade electronic health record (EHR)-based studies, today announced a collaboration with Amgen focused on the use of advanced data sources and artificial intelligence (AI) to achieve high-accuracy observational studies. The collaboration is focused on how current real-world evidence (RWE) techniques in cardiovascular medicine may be advanced with natural language processing and machine learning to achieve more timel...
Available Apr 30, After Hours